Bausch Health
BHC
#4665
Rank
โ‚น189.86 B
Marketcap
โ‚น511.84
Share price
-0.70%
Change (1 day)
-19.13%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): โ‚น84.70

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is โ‚น87.72. In 2024 the company made an earnings per share (EPS) of -โ‚น10.85 an increase over its 2023 EPS that were of -โ‚น146.50.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น84.70-880.53%
2024-โ‚น10.85-92.59%
2023-โ‚น146.50160.89%
2022-โ‚น56.15-76.64%
2021-โ‚น240.3668.45%
2020-โ‚น142.69-68.91%
2019-โ‚น458.93-57.11%
2018-โ‚น1,070-272.22%
2017โ‚น621.36-199.29%
2016-โ‚น625.78798.7%
2015-โ‚น69.63-128.31%
2014โ‚น245.97-204.62%
2013-โ‚น235.12602.7%
2012-โ‚น33.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น21.70-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น85.91-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA